Background: Malignant Non-Hodgkin's Lymphomas is one of the ten most common malignant diseases. Until recently, Chop regimen is considered as the standard treatment regimen for Non-Hodgkin's Lymphomas of intermediate and high grade.\r\n", u'Objectives: Assessing response rates, side effects, survival time and in treatment for these patients with CHOP regimen.\r\n', u'Subjects and methods: The controlled, prospective, descriptive study was carried out on 40 patients with Non-Hodgkin\u2019s Lymphomas of intermediate and high grade treated at the Military Hospital No 108.\r\n', u'Results and conclusion: The prevalence in men was higher than in women (77.5% compared to 22.5%). Complete remission accounts for 70%, part remission 15%, stable state of disease 5%, progressive disease 10%. Overall survival of 5 years is estimated at 37.23% disease-free survival of 5 years at 34.04%, event-free survival of 5 years at 32.46%, progressive-free survival of 5 years at 29.93%. There was a total of 241 chemical transmitted turns. Common side effects were nausea, vomiting, mouth ulcers, diarrhea and hair loss. This result was consistent with the results of previous studies.\r\n', u'
malignant Non-Hodgkin\u2019s Lymphomas ; CHOP regiment